Evaluation of Anthracycline-Induced Cardiotoxicity Using Proton Magnetic Resonance Spectroscopy Compared With Cardiac

Yulin Tu1, Xing-Yuan Kou1, Jinrong Zhou2

  • 1Department of Radiology, The Affiliated Hospital of Southwest Medical University.

Abstract

Insights

Proton magnetic resonance spectroscopy (¹H-MRS) detected increased Lipid1 levels at 6 weeks, enabling earlier diagnosis of anthracycline-induced cardiotoxicity (AIC) than traditional ejection fraction measurements.

Area of Science:

  • Cardiology
  • Oncology
  • Biomedical Imaging

Background:

  • Anthracycline-induced cardiotoxicity (AIC) is a severe complication limiting chemotherapy.
  • Current diagnostic methods for AIC lack sensitivity, necessitating improved early detection strategies.

Purpose of the Study:

  • To evaluate the potential of cardiac magnetic resonance (CMR) and proton magnetic resonance spectroscopy (¹H-MRS) for early detection of AIC.
  • To identify early biomarkers of AIC using ¹H-MRS.

Main Methods:

  • A prospective animal study involving 20 rabbits treated with adriamycin.
  • Weekly adriamycin administration with bi-weekly CMR and ¹H-MRS assessments.
  • Linear mixed models and ROC analysis to determine diagnostic thresholds and timing.

Main Results:

  • Lipid1 levels significantly increased at week 6, preceding the decrease in left ventricular ejection fraction (LVEF) at week 8.
  • A Lipid1 cutoff of 2.60 demonstrated high diagnostic accuracy (AUC=0.745) for AIC at week 6.
  • Lipid1 showed a moderate negative correlation with LVEF (r=-0.418).

Conclusions:

  • ¹H-MRS-detected Lipid1 increase serves as an early indicator of AIC.
  • This method offers a more sensitive approach for early AIC diagnosis compared to LVEF assessment.